7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
    		                             
      cash flows from operating activities:
    		                             
      net income
    		18,865,000 14,701,000 7,990,000 12,306,000 11,554,000 6,402,000 1,907,000 -6,348,000 -29,217,000 -13,193,000 -2,529,000 -8,494,000 -6,451,000 -3,756,000 -5,715,000 -8,480,000 -5,272,000 -1,881,000 -3,801,000 -3,768,000 -3,184,000 -2,808,000 -1,442,000 -934,000 173,000 -1,974,000 -4,382,000 -6,925,000 -3,808,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                             
      depreciation and amortization expense
    		811,000 918,000 1,221,000 1,555,000 1,618,000 1,236,000 1,263,000 1,075,000 2,251,000 1,463,000 1,407,000 1,522,000 1,410,000 1,405,000 1,511,000 1,464,000 1,298,000 1,136,000 1,174,000 1,176,000 731,000 594,000 849,000 593,000 588,000 524,000 481,000   
      stock-based compensation expense
    		6,728,000 6,560,000 5,420,000 5,310,000 5,446,000 5,340,000 4,518,000 4,813,000 5,644,000 7,130,000 6,509,000 6,623,000 7,233,000 7,600,000 7,530,000 7,063,000 8,348,000 7,089,000 7,520,000 6,189,000 7,200,000 6,250,000 4,540,000 3,464,000 3,269,000 3,238,000 2,750,000 3,245,000 2,586,000 
      benefit from bad debt
    		   -3,000 8,000 -10,000 18,000  -38,000 -21,000 245,000         90,000 -2,000 -4,000 21,000 -1,000 57,000     
      unrealized foreign currency transaction losses
    		          9,000    7,000               
      litigation accrual settled with sale of assets
    		0                             
      changes in operating assets and liabilities:
    		                             
      accounts receivable
    		-13,229,000 6,843,000 -457,000 -13,099,000 -219,000 -9,737,000 -17,123,000 952,000 -63,000 17,157,000 -9,827,000 10,239,000 -3,878,000 9,974,000 -10,973,000 8,849,000 1,365,000 3,239,000 -2,942,000 -4,642,000 -5,036,000 -830,000 -3,462,000 -2,305,000 -5,818,000 1,287,000 -8,396,000 4,329,000 -4,070,000 
      prepaid expenses and other current assets
    		-3,693,000 -1,491,000 496,000 128,000 -1,002,000 342,000 972,000 -1,675,000 770,000 158,000 1,709,000 -815,000 -1,046,000 -114,000 -136,000 -2,701,000 -849,000 -264,000 172,000 -1,425,000 -1,588,000 3,730,000 -94,000 -3,855,000 -1,781,000 -131,000 158,000 189,000 327,000 
      commissions receivable, current and non-current
    		0 859,000 1,014,000 1,158,000 1,078,000 1,321,000 1,323,000 1,565,000 2,740,000 -724,000 595,000                   
      operating lease right-of-use assets
    		285,000 281,000 267,000 371,000 590,000 755,000 497,000 491,000 632,000 686,000 688,000 662,000 664,000 642,000 645,000 674,000 636,000 609,000 791,000           
      other assets
    		   0 0   385,000 0 0 36,000 14,744,000 -3,511,000 -5,691,000 -5,561,000 -9,805,000 -749,000 393,000 -733,000 -332,000 -165,000 -53,000 -4,000 1,000      
      accounts payable
    		8,955,000 1,747,000 -2,765,000 12,961,000 5,220,000 8,615,000 15,868,000 -3,382,000 -2,217,000 -7,816,000 4,000 -6,496,000 4,207,000 -9,883,000 13,296,000 4,654,000 -1,499,000 -6,421,000 -702,000 -729,000 6,737,000 -690,000 3,983,000 305,000 5,003,000 -3,102,000 4,631,000 2,538,000 -799,000 
      accrued expenses and other current liabilities
    		1,599,000 -12,306,000 10,018,000 -73,000 75,000 -832,000 1,870,000 1,979,000 -3,791,000 -583,000 852,000 891,000 -1,207,000 798,000 -2,857,000 -7,123,000 2,277,000 4,728,000 2,810,000 -1,643,000 925,000 -2,761,000 -489,000 6,712,000 3,061,000 -687,000 1,040,000 -43,000 504,000 
      deferred revenue
    		-257,000 -454,000 335,000 -14,000 -120,000 29,000 -2,000 -29,000 92,000 -138,000 80,000 -23,000 -84,000 -10,000 -112,000 204,000 56,000 24,000 -57,000 177,000 59,000 56,000 76,000 -66,000 -194,000 91,000 230,000 371,000 -83,000 
      operating lease liabilities
    		-292,000 -277,000 -268,000 -384,000 -693,000 -793,000 -667,000 -658,000 -705,000 -741,000 -902,000 -749,000 -779,000 -692,000 -663,000 -772,000 -731,000 -699,000 -638,000           
      net cash from operating activities
    		19,768,000 25,297,000 23,306,000 20,134,000 23,614,000 12,378,000 10,440,000 -792,000 -4,147,000 3,348,000 -1,237,000 -4,898,000 -3,520,000 -3,528,000 -3,845,000 -6,859,000 2,813,000 7,715,000 3,520,000 -3,235,000 5,995,000 3,981,000 3,927,000 3,956,000 4,299,000 -360,000 -3,482,000 4,109,000 -5,007,000 
      capex
    		-1,302,000 -1,505,000 -925,000 -1,003,000 -1,724,000 -532,000 -745,000 -852,000 -955,000 -1,015,000 -940,000 -1,038,000 -1,235,000 -1,585,000 -372,000 -534,000 -1,032,000 -533,000 -777,000 -1,114,000 -837,000 -986,000 -885,000 -777,000 -646,000 -885,000 -667,000 -1,192,000 -834,000 
      free cash flows
    		18,466,000 23,792,000 22,381,000 19,131,000 21,890,000 11,846,000 9,695,000 -1,644,000 -5,102,000 2,333,000 -2,177,000 -5,936,000 -4,755,000 -5,113,000 -4,217,000 -7,393,000 1,781,000 7,182,000 2,743,000 -4,349,000 5,158,000 2,995,000 3,042,000 3,179,000 3,653,000 -1,245,000 -4,149,000 2,917,000 -5,841,000 
      cash flows from investing activities:
    		                             
      acquisition of property and equipment, including costs capitalized for development of internal-use software
    		-1,302,000 -1,461,000 -1,133,000 -1,003,000 -1,489,000 -852,000 -770,000 -852,000 -966,000 -1,015,000 -1,007,000 -1,071,000 -1,230,000 -1,308,000 -681,000 -587,000 -965,000 -533,000 -777,000 -1,114,000 -837,000 -986,000 -885,000 -777,000 -646,000 -885,000 -667,000 -1,192,000 -1,081,000 
      net cash from investing activities
    		-1,302,000 -1,461,000 -1,133,000 -1,003,000 -1,489,000 -852,000 -770,000 -852,000 12,228,000 -1,015,000 -1,007,000 -1,071,000 -1,230,000 -1,308,000 -681,000 -587,000 -16,920,000 -533,000 -777,000 -1,114,000 -15,767,000 -986,000 -885,000 -777,000 -646,000 -885,000 -667,000 -1,192,000 -1,081,000 
      cash flows from financing activities:
    		                             
      proceeds from exercise of stock options
    		1,059,000 373,000 1,962,000 651,000 288,000 1,186,000 1,428,000 639,000 0 53,000 287,000 212,000 122,000 50,000 558,000 524,000 1,367,000 452,000 1,272,000 1,345,000 1,244,000 954,000 1,364,000 926,000 1,173,000 649,000 234,000 8,000 276,000 
      repurchase of common stock
    		                             
      tax withholding payments related to net share settlement
    		-918,000 -986,000 -1,293,000 -496,000 -507,000 -414,000 -429,000 -103,000 -67,000 -102,000 -130,000 -21,000 -28,000                 
      net cash from financing activities
    		-20,883,000 -613,000 669,000 155,000 -219,000 772,000 999,000 536,000 -67,000 -49,000 157,000 191,000 94,000 -1,000 15,558,000 524,000 1,367,000 452,000 1,272,000 1,345,000 1,244,000 954,000 1,364,000 926,000 1,173,000 649,000 234,000 8,000 42,415,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-5,000 -3,000 10,000 -11,000 16,000 1,000 -5,000 15,000 -13,000 11,000 5,000 22,000 -22,000 -22,000 -5,000 0 -7,000 0 1,000           
      net increase in cash, cash equivalents and restricted cash
    		-2,422,000 23,220,000 22,852,000 19,275,000 21,922,000 12,299,000 10,664,000 -1,093,000 8,001,000 2,295,000 -2,082,000  -4,678,000 -4,859,000 11,027,000   7,634,000 4,016,000 -3,011,000 -8,528,000 3,949,000 4,406,000 4,105,000 4,826,000 -596,000 -3,915,000   
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 102,116,000 0 0 0 37,956,000 0 0 0 30,835,000 0 0 0 35,101,000 0 0 0 43,120,000 0 0 0 46,304,000 0 0 0 41,884,000   
      cash, cash equivalents and restricted cash at end of period
    		-2,422,000 23,220,000 124,968,000 19,275,000 21,922,000 12,299,000 48,620,000 -1,093,000 8,001,000 2,295,000 28,753,000 -5,756,000 -4,678,000 -4,859,000 46,128,000 -6,922,000 -12,747,000 7,634,000 47,136,000 -3,011,000 -8,528,000 3,949,000 50,710,000 4,105,000 4,826,000 -596,000 37,969,000   
      supplemental disclosure of non-cash information:
    		                             
      acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities
    		0 -44,000 208,000  -235,000 320,000 25,000  11,000                     
      assets sold in settlement of litigation accrual
    		0                             
      operating lease liabilities arising from obtaining right-of-use assets
    		   0 1,332,000       0 0 529,000 567,000 0 143,000 0 240,000           
      unrealized foreign currency transaction (gains) losses
    		 75,000 35,000 -82,000 59,000 1,000 -4,000     25,000 -18,000      15,000           
      supplemental disclosure of non-cash investing information:
    		                             
      loss on sale of health assets
    		       0                      
      impairment of right-of-use asset
    		       0                      
      change in fair value of contingent consideration liabilities
    		       0 0 -37,000 -113,000  -95,000 -3,780,000 -892,000               
      proceeds from sale of health assets
    		       0                      
      proceeds from private placement of common stock
    		           0 0 0 15,000,000               
      supplemental disclosure of cash flow information:
    		                             
      cash paid for income taxes
    		                             
      supplemental disclosure of noncash investing and financing information:
    		                             
      acquisition of property and equipment included in accounts payable
    		          67,000 33,000 -5,000 -277,000 309,000 53,000 -67,000             
      issuance of class a common stock to settle contingent consideration liabilities
    		                             
      issuance of class a common stock in settlement of stock-based compensation liability
    		                             
      deferred taxes
    		               0              
      benefit from (recovery of) bad debt
    		           581,000 35,000 2,000 75,000 9,000 0 -4,000 -46,000           
      changes in operating assets and liabilities, net of effects from acquisition:
    		                             
      other long-term liabilities
    		               -964,000 26,000 -32,000 36,000 51,000 318,000         
      acquisition of business
    		               0    0          
      fair value of contingent consideration in connection with acquisition included in liabilities
    		                             
      reconciliation of cash, cash equivalents and restricted cash:
    		                             
      cash and cash equivalents
    		           -5,756,000 -4,678,000 -4,859,000 46,128,000 -6,922,000 -12,747,000 7,634,000 46,886,000 -3,011,000 -8,528,000 3,949,000 50,460,000       
      restricted cash
    		               0 0 0 250,000 0 0 0 250,000       
      total cash, cash equivalents and restricted cash shown in the statement of cash flows
    		           -5,756,000 -4,678,000 -4,859,000 46,128,000 -6,922,000 -12,747,000 7,634,000 47,136,000 -3,011,000 -8,528,000 3,949,000 50,710,000       
      unrealized foreign currency transaction gains
    		                             
      supplemental disclosure of non-cash investing and financing information:
    		                             
      change in fair value of contingent consideration
    		               60,000 425,000 -210,000 -79,000           
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                             
      net decrease in cash, cash equivalents and restricted cash
    		                             
      fair value of contingent consideration in connection with acquisition included in stockholders' equity
    		                             
      issuance of class a common stock to settle stock-based compensation liability
    		                             
      direct channels
    		                             
      indirect channels
    		                             
      fair value of contingent consideration in connection with acquisition included in accrued expenses and other long-term liabilities
    		                             
      loss on disposal of property and equipment
    		                             
      fair value of contingent consideration in connection with acquisition included in stockholders’ equity
    		                             
      fair value of contingent consideration in connection with acquisition included in other long-term liabilities
    		                   0          
      fair value of contingent consideration in connection with acquisition included in equity
    		                             
      computer equipment
    		                             
      software
    		                             
      furniture and fixtures
    		                             
      leasehold improvements
    		                             
      deferred rent
    		                      -51,000 -56,000 -57,000 -28,000 6,000 18,000 -6,000 
      noncash interest expense
    		                           0 0 
      proceeds from initial public offering, net of underwriting discounts and commissions
    		                           0  
      proceeds from borrowings on line of credit
    		                           0 0 
      repayments of borrowings on line of credit
    		                           0 -6,983,000 
      repayments of term loan
    		                           0 0 
      payments of initial public offering costs
    		                           0 -3,191,000 
      supplemental disclosure of cash flow information
    		                             
      cash paid for interest
    		                             
      conversion of convertible preferred stock to common stock
    		                           0  
      accretion of redeemable convertible preferred stock to redemption value
    		                           0 0 
      purchases of property and equipment included in accounts payable
    		                            247,000 
      deferred initial public offering costs included in accounts payable or accrued expenses
    		                             
      conversion of series b redeemable convertible preferred stock to series b-1 redeemable convertible preferred stock
    		                             
      retirement of treasury stock
    		                             
      depreciation and amortization
    		                            342,000 
      net increase in cash and cash equivalents
    		                             
      cash and cash equivalents at beginning of period
    		                             
      cash and cash equivalents at end of period
    		                             
      net increase in cash
    		                             
      cash at beginning of period
    		                             
      cash at end of period
    		                             
      conversion of series a redeemable convertible preferred stock to common stock
    		                             
      accrued advertising expenses
    		                             
      accrued employee compensation and benefits
    		                             
      accrued professional fees
    		                             
      other current liabilities
    		                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.